Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise.

Nader E, Skinner S, Romana M, Fort R, Lemonne N, Guillot N, Gauthier A, Antoine-Jonville S, Renoux C, Hardy-Dessources MD, Stauffer E, Joly P, Bertrand Y, Connes P. · 2019

Read Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise. by Nader E, Skinner S, Romana M, Fort R, Lemonne N, Guillot N, Gauthier A, Antoine-Jonville S, Renoux C, Hardy-Dessources MD, Stauffer E, Joly P, Bertrand Y, Connes P. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6842957.txt.

Introduction

Nader and co-authors review blood rheology in Frontiers in Physiology. Rheology is the study of how blood flows. Blood thins as it moves faster, a trait set by the share of red cells, the plasma, and how red cells clump and bend. In the smallest vessels, that bending matters most. Small changes can alter flow to tissues.

The review sets out the key measures and what shifts them. It then turns to sickle cell disease, where stiff, misshapen red cells disturb flow and drive crises. Walking tests link poor red cell flexibility to worse exercise capacity in patients. A final section weighs what exercise does to these measures, and what forms may be safe.

Catalog record

CREATORNader E, Skinner S, Romana M, Fort R, Lemonne N, Guillot N, Gauthier A, Antoine-Jonville S, Renoux C, Hardy-Dessources MD, Stauffer E, Joly P, Bertrand Y, Connes P.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE84 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6842957

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise By Elie Nader, Sarah Skinner, Marc Romana, Romain Fort, Nathalie Lemonne, Nicolas Guillot, Alexandra Gauthier, Sophie Antoine-Jonville, Céline Renoux, Marie-Dominique Hardy-Dessources, Emeric Stauffer, Philippe Joly Published in: Frontiers in Physiology DOI: 10.3389/fphys.2019.01329 ABSTRACT Blood viscosity is an important determinant of local flow characteristics, which exhibits shear thinning behavior: it decreases exponentially with increasing shear rates. Both hematocrit and plasma viscosity influence blood viscosity. The shear thinning property of blood is mainly attributed to red blood cell (RBC) rheological properties. RBC aggregation occurs at low shear rates, and increases blood viscosity and depends on both cellular (RBC aggregability) and plasma factors. Blood flow in the microcirculation is highly dependent on the ability of RBC to deform, but RBC deformability also affects blood flow in the macrocirculation since a loss of deformability causes a rise in blood viscosity. Indeed, any changes in one or several of these parameters may affect blood viscosity differently. Poiseuille’s Law predicts that any increase in blood viscosity should cause a rise in vascular resistance. However, blood viscosity, through its effects on wall shear stress, is a key modulator of nitric oxide (NO) production by the endothelial NO-synthase. Indeed, any increase in blood viscosity should promote vasodilation. This is the case in healthy individuals when vascular function is intact and able to adapt to blood rheological strains. However, in sickle cell disease (SCD) vascular function is impaired. In this context, any increase in blood viscosity can promote vaso-occlusive like events. We previously showed that sickle cell patients with high blood viscosity usually have more frequent vaso-occlusive crises than those with low blood viscosity. However, while the deformability of RBC decreases during acute vaso-occlusive events in SCD, patients with the highest RBC deformability at steady-state have a higher risk of developing frequent painful vaso-occlusive crises. This paradox seems to be due to the fact that in SCD RBC with the highest deformability are also the most adherent, which would trigger vaso-occlusion. While acute, intense exercise may increase blood viscosity in healthy individuals, recent works conducted in sickle cell patients have shown that light cycling exercise did not cause dramatic changes in blood rheology. Moreover, regular physical exercise has been shown to decrease blood viscosity in sickle cell mice, which could be beneficial for adequate blood flow and tissue perfusion. BLOOD FLOW RESISTANCE AND THE CARDIOVASCULAR SYSTEM Flow velocity in a given tube depends on pressure and flow resistance. According to Poiseuille’s Law (Poiseuille, 1835), flow resistance depends on the geometry of the tube [length (L) and radius of the tube (r)] and the fluid’s viscosity (η), and is calculated using the following formula: [formula: R=8⁢η⁢Lπ⁢r4] When applying Poiseuille’s Law to the cardiovascular system, one must consider the radius and the length of the vessels, and the viscosity of the blood. The dimensions of the vascular system (most notably the radius, which is raised to the fourth power) play a more important role in determining vascular resistance than blood viscosity does. However, several works conducted in the past 10–15 years have shown that, in a physiological context, the parameters of this equation cannot be considered to be truly independent of each other. This is because vessels are not rigid tubes; they can change their diameters in response to various physiological stimuli. One of the most important molecules that promotes an augmentation in vascular diameter (i.e., vasodilation) is nitric oxide (NO). Martini et al. (2005), Tsai et al. (2005), Intaglietta (2009), and Sriram et al. (2012) showed that mild to moderate increases in hematocrit and blood viscosity did not result in a rise in vascular resistance or blood pressure, but actually caused the opposite effect. They also showed that increasing blood viscosity promoted the activation of endothelial NO-synthase through shear stress-dependent mechanisms, resulting in higher NO production, compensatory vasodilation, and decreased arterial pressure. However, evidence shows that these vascular adaptations can only occur in a functioning vascular system with a healthy endothelium. When vascular dysfunction is present, vasodilation is impaired. Therefore, a rise in blood viscosity is not accompanied by an increase in vasodilation. As a result, vascular resistance and arterial pressure increase (Vazquez et al., 2010; Salazar Vazquez et al., 2011). Although the role of blood viscosity in vascular adaptations is often ignored, these studies clearly demonstrate that vascular geometry and blood viscosity should not be considered separately when studying the regulation of vascular resistance in healthy populations or in people with cardiovascular diseases. BLOOD IS NOT A SIMPLE FLUID Whole blood is a two-phase liquid, composed of cellular elements suspended in plasma, an aqueous solution containing organic molecules, proteins, and salts (Baskurt and Meiselman, 2003). The cellular phase of blood includes, erythrocytes, leukocytes, and platelets. White blood cells and platelets can affect blood rheology, but under normal conditions, red blood cells (RBCs) have the biggest influence (Pop et al., 2002). Blood rheological properties are determined by the physical properties of these two phases and their relative contribution to total blood volume. Blood is a non-Newtonian, shear thinning fluid with thixotropic and viscoelastic properties. Many cardiovascular handbooks consider blood viscosity values between 3.5 and 5.5 cP to be normal. However, blood viscosity cannot be summarized by a single value. Due to the shear thinning property of blood, which is dependent on RBC rheological properties, the viscosity of this fluid changes depending on the hemodynamic conditions. The same blood can have a viscosity value of 60 cP at a shear rate of 0.1 s–1, whereas the viscosity would be 5 or 6 cP at a shear rate of 200 s–1. This means that blood viscosity is different in the large arteries, the veins, and the microcirculation, where shear rate can vary from few s–1 to more than 1000 s–1 (Connes et al., 2016). Blood viscosity depends on several factors: hematocrit, plasma viscosity, the ability of RBCs to deform under flow, and RBC aggregation-disaggregation properties (Baskurt and Meiselman, 2003; Cokelet and Meiselman, 2007). Effect of Hematocrit Whole blood viscosity is dependent on the number (and volume) of erythrocytes in the blood, and is thus linearly related to hematocrit (Chien et al., 1975). The impact of hematocrit on blood viscosity is much higher at low shear rates (veins for instance) than at high shear rate (arteries for instance) (Cokelet and Meiselman, 2007). At high shear rate, it is estimated that a rise of hematocrit of one unit would cause an increase of blood viscosity of 4% (if RBC rheological properties remain the same). Plasma Viscosity Plasma is a newtonian fluid, which means that its viscosity does not vary with shear rate. The viscosity of plasma is dependent on the concentration of plasma proteins, such as fibrinogen, α1-globulins, α2-globulins, β-globulins, and γ-globulins (Connes et al., 2008). Any elevation in the concentration of these proteins can cause plasma, and thus whole blood, viscosity to increase (Kesmarky et al., 2008). Normal plasma at 37 degrees Celsius has a viscosity of around 1.2–1.3 cP, but these values may be higher in various inflammatory, metabolic, or cardiovascular diseases (Kesmarky et al., 2008). Furthermore, increased plasma viscosity is associated with higher rates of adverse clinical events in unstable angina pectoris and stroke

Read the complete text